ARYX (ARYx Therapeutics) Shares Buyback Ratio %: -21.81 (As of Aug. 28, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is ARYx Therapeutics Shares Buyback Ratio %?

ARYx Therapeutics ARYX -99.80% Shares Buyback Ratio % is -21.81 as of Aug. 28, 2026.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. ARYx Therapeutics's current shares buyback ratio was -21.81%.

ARYx Therapeutics Shares Buyback Ratio % Related Terms

ARYx Therapeutics Shares Buyback Ratio % Historical Data

* Premium members only.

The historical data trend for ARYx Therapeutics's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ARYx Therapeutics Shares Buyback Ratio % Chart

ARYx Therapeutics Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09
Shares Buyback Ratio %
Get a 7-Day Free Trial 0.00 0.00 -0.67 -55.05 -2.42

ARYx Therapeutics Quarterly Data
Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.48 -2.05 -19.36 0.00 0.00

ARYx Therapeutics Shares Buyback Ratio % Calculation

ARYx Therapeutics's Shares Buyback Ratio for the fiscal year that ended in Dec. 2009 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2008 ) - Shares Outstanding (EOP) (A: Dec. 2009 )) / Shares Outstanding (EOP) (A: Dec. 2008 )
=(27.372 - 28.034) / 27.372
=-2.42%

ARYx Therapeutics's Shares Buyback Ratio for the quarter that ended in Sep. 2010 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2010 ) - Shares Outstanding (EOP) (A: Sep. 2010 )) / Shares Outstanding (EOP) (A: Jun. 2010 )
=(33.462 - 33.462) / 33.462
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Shares Buyback Ratio % →
What does a Shares Buyback Ratio % of -21.81 mean?
ARYx Therapeutics (ARYX) has a Shares Buyback Ratio % of -21.81 as of Aug. 28, 2026. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on ARYx Therapeutics and its competitors.
Is ARYx Therapeutics' Shares Buyback Ratio % too high?
ARYx Therapeutics' current Shares Buyback Ratio % is -21.81.
How does ARYx Therapeutics' Shares Buyback Ratio % compare to YBAO and HPMM?
ARYx Therapeutics' Shares Buyback Ratio % of -21.81 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Buyback Ratio % for a Drug Manufacturers company?
A good Shares Buyback Ratio % depends on the Drug Manufacturers industry context. However, Shares Buyback Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Buyback Ratio % mean?
A high Shares Buyback Ratio % can signal that a stock is expensive relative to its fundamentals. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on ARYx Therapeutics and its competitors. ARYx Therapeutics's current Shares Buyback Ratio % is -21.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ARYx Therapeutics stock overvalued right now?
ARYx Therapeutics (ARYX) has a current Shares Buyback Ratio % of -21.81. The current Shares Buyback Ratio % is -21.81. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Buyback Ratio % calculated?
Shares Buyback Ratio % is calculated from a company's financial statements. For ARYx Therapeutics (ARYX), the current Shares Buyback Ratio % is -21.81 as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ARYx Therapeutics Business Description

Address 6300 Dumbarton Circle, Fremont, CA, USA, 94555
ARYx Therapeutics Inc is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates designed to eliminate known safety issues associated with well-established, commercially successful drugs.